How Does Hormone Testing Work for Women in Their 40s?

What Does Hormone Testing Actually Measure in Perimenopause?

Hormone testing in perimenopause is fundamentally different from testing in your 20s or 30s. Before perimenopause, your hormones follow a predictable monthly rhythm. In your 40s, that rhythm breaks down.

Estradiol, the primary form of estrogen your ovaries produce, begins to decline. Not in a straight line, though. It surges, crashes, flatlines, then surges again. Progesterone drops earlier and more consistently, especially if you're not ovulating regularly. FSH (follicle-stimulating hormone) rises as your brain tries to coax your ovaries into producing more estrogen, and LH (luteinizing hormone) follows a similar pattern.

The practical problem: these hormones can look completely different depending on which day of your cycle you test. A single blood draw might catch estradiol at 200 pg/mL one week and 40 pg/mL the next. Both results are real. Neither tells you what's happening across the full month. A longitudinal study of 127 perimenopausal women tracked estradiol and progesterone over 13 months and found fluctuation at every single measurement point, with no consistent pattern predicted by either time or how far along a woman was in the transition.¹ That's the research basis for why a pre-treatment panel so often fails to earn its cost.

What Is Serum Testing Actually Measuring?

Serum testing is, in a real sense, testing water. Blood is a water-based substrate. Hormones are lipids, built on cholesterol backbones. For a lipid to stay suspended in water it has to bind to a carrier protein. So when you measure a hormone in serum, what you're largely measuring is the fraction bound to those carrier proteins. That fraction carries a lot of variability.

This doesn't make serum useless. It's a consistent metric, and consistency has value, particularly for watching a trend over time. But you have to understand what you're actually measuring rather than treating the number as a direct readout of how much hormone your tissues are getting.

Why Doesn't Any Test Report Receptor Receptivity?

Even a perfectly accurate hormone level doesn't tell you how receptive your receptor sites are. Receptivity varies widely, and independently of how much hormone your body is making or carrying.

A few of the things that move it:

• Thyroid activity. Reproductive hormone uptake changes with thyroid function and thyroid presence. This is one reason thyroid markers are usually run alongside sex hormones.
• Cortisol. When the body perceives a stressor, it preferentially takes up cortisol, because cortisol is required for survival and for damping inflammation. Estrogen receptors aren't particularly selective, so cortisol can occupy them, displacing estrogen (or progesterone) that would otherwise have bound there. High cortisol can therefore produce low-estrogen symptoms in a woman whose measured estrogen looks adequate.
• Nutrient status. Depletion can radically impair receptor function; zinc, magnesium, and selenium all interact with a hormone's ability to occupy its receptor site.

None of this appears on a hormone panel. It's a large part of why two women with near-identical labs can feel completely different.

Why Does Everyone Need SHBG Tested?

Because SHBG (sex hormone binding globulin) decides how much of your estradiol, progesterone, and testosterone is actually free to act on tissue, versus bound to a carrier protein and functionally locked away. A standard panel reports total hormone. It doesn't report how much of that total your body can actually use. That gap is exactly why a "normal" total number can sit next to real symptoms: if SHBG runs high, less of that hormone is free and bioavailable, even though the total on the page looks fine.

What actually moves it, and in which direction:

• Insulin resistance lowers SHBG. This relationship is well-documented enough that low SHBG functions as a PCOS marker in its own right.¹
• Oral estrogen raises SHBG substantially. Oral estradiol increases hepatic SHBG production by roughly 67 to 171 percent in postmenopausal women, well beyond what transdermal estradiol does, because oral dosing passes through the liver first and drives up binding-protein production there.² Transdermal routes largely bypass this effect.
• Oral progesterone can raise SHBG too, in a specific group. In clinical practice, this shows up most in women whose liver detoxification capacity is already taxed: sluggish phase II clearance, a history of hormonal birth control, chronic alcohol use, or a real environmental toxin burden. This is a clinical observation from practice, not yet a population-level finding in the published literature, and it's flagged that way on purpose.
• Hyperthyroidism and impaired liver clearance also raise it. Hypothyroidism lowers it, right alongside insulin resistance.

None of this shows up unless SHBG is actually ordered. That's the case for making it a standard part of every panel, not an optional add-on: a woman with a "normal" estradiol and real symptoms may be looking at a bioavailability problem the total-hormone number can't show her.

What Does Urine Testing Add, and Where Does It Fall Short?

Urine hormone testing reflects what's being cleared rather than what's circulating, and it captures metabolites serum doesn't. Research claiming it matches serum accuracy comes mostly from the labs that sell dried-urine panels and hasn't been independently replicated at scale, so bring "as accurate as serum" to your practitioner as a manufacturer claim, not a settled fact.

What urine testing doesn't do is solve the underlying problem. The volatility of hormone fluctuation in perimenopause leaves urine with the same core limitation serum has. Changing the sample type doesn't stabilize a moving target.

What Does a Standard Perimenopause Hormone Panel Include?

A standard perimenopause hormone panel usually includes:

• Estradiol — the form of estrogen that drives most symptoms when it's low or erratic
• Progesterone — the calming hormone that drops first; low progesterone often shows up as insomnia, anxiety, or heavy cycles
• FSH — elevated FSH (commonly cited above roughly 25-30 mIU/mL) signals your ovaries are struggling to respond, though a single elevated reading in perimenopause is not diagnostic on its own given the fluctuation described above
• LH — rises alongside FSH in perimenopause
• Testosterone and other androgens — often decline in your 40s; affect energy, libido, muscle mass, and motivation
• DHEA-S — an adrenal androgen that supports resilience and metabolic function; declines with age
• TSH, Free T3, Free T4 — thyroid function affects everything from metabolism to mood, and affects hormone uptake directly
• Prolactin — can be elevated in perimenopause and affect cycle regularity
• SHBG (sex hormone binding globulin) — should be standard, not optional; it determines how much of your total hormone is actually free to act on tissue, and it's frequently skipped

Cortisol also matters, both for stress response and for the receptor competition described above. For the full high-yield list, including the non-sex-hormone labs (ferritin, fasting insulin, vitamin D) that often matter more than a sex hormone panel does, see What Are the Best Labs to Test During Perimenopause?

When Does Hormone Testing Actually Help?

Before hormone therapy, the history usually beats the panel. In practice, the decision to start is made from a careful account of symptoms, general age range, and reproductive history, not from a pre-treatment hormone panel. Fluctuation makes those numbers unreliable enough that they rarely change the decision. That's a clinical judgment your own prescriber makes with you, and it's worth asking them directly what a given test would actually change.

Everyone tends to start at the same lowest introductory dose regardless of labs. This explains why pre-treatment numbers so often don't alter the plan. The reasoning is physiological: a woman may have been hormone-naive for a long time, and starting low lets the body adjust as receptors wake up. It minimizes symptoms at introduction and allows a slow, measured upward taper where she observes what dose actually feels best in her own body. This describes how the approach works in practice. It is not a protocol to act on. Dose, form, and any adjustment are decisions for your prescriber.

Once you're on hormones, testing earns its place. With exogenous hormones added to your own output, there's much less fluctuation and the trends become far more predictable. This is the point where numbers start reflecting something stable enough to act on, and where retesting to track a change genuinely tells you something.

Timing, precisely. When you test matters as much as what you test.

Day 1 is the first day of bleeding. If your cycles are irregular or absent, your provider will advise on timing, and repeat testing is often needed to see a pattern rather than a single point.

Functional ranges matter more than lab reference ranges, within limits. A ferritin of 22 ng/mL or an estradiol of 50 pg/mL might be flagged as "normal," but functional medicine practitioners look for optimal thresholds instead of the wide conventional range. For progesterone, a level above 10 ng/mL in the luteal phase is commonly used as a marker that ovulation happened. For TSH, functional practitioners commonly target roughly 0.5-2.5 mIU/L, narrower than the standard lab range of about 0.5-4.5. That narrower range is clinical convention, not a diagnostic cutoff. A result outside it belongs in a conversation with your practitioner.

Symptom correlation is the key. A lab result only matters if it connects to what you're feeling, and given everything above about carrier proteins and receptor receptivity, the symptom picture is often the more reliable signal. This is why the Reverse Age Method starts with symptom tracking before layering in labs. The experience drives the interpretation.

The lab-read feature in the Reverse Age Method lets you upload a hormone panel and receive interpretation based on functional thresholds and symptom correlation. The system is built on Claude and trained on 27 years of clinical protocols. It's available to all members as part of the program and uses your personal symptom data to contextualize the numbers. It educates and directs. It does not diagnose or prescribe. You bring the results to your provider for treatment decisions.

When Should You Get Additional Support Beyond a Standard Panel?

If your symptoms are affecting daily function (sleep, cognition, mood, metabolic health), work with a practitioner who understands perimenopause and hormone restoration. Not all providers interpret labs through a functional lens, and many will tell you that low-normal results don't warrant treatment. Equally, some will insist on a full panel before they'll discuss anything, when a careful symptom and reproductive history would move faster. If either response leaves you stuck and still symptomatic, consider a second opinion from a functional medicine practitioner, naturopathic doctor, or menopause-specialized provider. Is Root-Cause Medicine Right for Perimenopause, or Is That Just Marketing? covers how to tell the difference between a practitioner sequencing your care well and one selling a shortcut, and Integrative vs. Standard Care: What Should a Woman in Perimenopause Actually Expect From Each? lays out what each model actually offers so you know what you're walking into.